UniProtKB/Swiss-Prot P32004 : Variant p.Glu309Lys
Neural cell adhesion molecule L1
Gene: L1CAM
Feedback ?
Variant information
Variant position:
309
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:
LP/P [Disclaimer : Variants classification is intended for research purposes only, not for clinical and diagnostic use . The label disease variant is assigned according to literature reports on probable disease-association that can be based on theoretical reasons. This label must not be considered as a definitive proof for the pathogenic role of a variant. ]
The variants are classified into three categories: LP/P, LB/B and US.LP/P: likely pathogenic or pathogenic. LB/B: likely benign or benign. US: uncertain significance
Residue change:
From Glutamate (E) to Lysine (K) at position 309 (E309K, p.Glu309Lys).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:
Change from medium size and acidic (E) to large size and basic (K)
The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:
1
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another: Lowest score: -4 (low probability of substitution).Highest score: 11 (high probability of substitution). More information can be found on the following page
Variant description:
In MASA; decrease in neurite outgrowth, when assayed in NGF-treated pheochromocytoma PC12 cells; decrease in cell-matrix adhesion; decreased cell migration; no effect on axon guidance, on subcellular location to synaptic terminals, nor on proper synapse formation, when assayed in a heterologous system; no effect on the localization at the cell surface; no effect on cell proliferation, when transfected in pheochromocytoma PC12 cells.
Any additional useful information about the variant.
Other resources:
Links to websites of interest for the variant.
Sequence information
Variant position:
309
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:
1257
The length of the canonical sequence.
Location on the sequence:
TYQNHNKTLQLLKVGEEDDG
E YRCLAENSLGSARHAYYVTV
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:
The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human TYQNHNKTLQLLKVGEEDDGE YRCLAENSLGSARHAYYVTV
Mouse IYQNHNKTLQLLNVGEEDDGE YTCLAENSLGSARHAYYVTV
Rat IYQNHNKTLQLLNVGEEDDGE YTCLAENSLGSARHAYYVTV
Sequence annotation in neighborhood:
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
20 – 1257
Neural cell adhesion molecule L1
Topological domain
20 – 1120
Extracellular
Domain
240 – 328
Ig-like C2-type 3
Glycosylation
294 – 294
N-linked (GlcNAc...) asparagine
Disulfide bond
264 – 312
Literature citations
New domains of neural cell-adhesion molecule L1 implicated in X-linked hydrocephalus and MASA syndrome.
Jouet M.; Moncla A.; Paterson J.; McKeown C.; Fryer A.; Carpenter N.; Holmberg E.; Wadelius C.; Kenwrick S.;
Am. J. Hum. Genet. 56:1304-1314(1995)
Cited for: VARIANTS MASA LYS-309 AND LEU-941; VARIANTS HYCX SER-9; SER-121; PHE-768; LEU-941 AND CYS-1070;
L1CAM and its cell-surface mutants: new mechanisms and effects relevant to the physiology and pathology of neural cells.
Tagliavacca L.; Colombo F.; Racchetti G.; Meldolesi J.;
J. Neurochem. 124:397-409(2013)
Cited for: CHARACTERIZATION OF VARIANTS MASA GLN-210 AND LYS-309; CHARACTERIZATION OF VARIANTS HYCX THR-219 AND CYS-264; CHARACTERIZATION OF VARIANT HYCX/MASA LEU-941; SUBCELLULAR LOCATION;
Differential effects of human L1CAM mutations on complementing guidance and synaptic defects in Drosophila melanogaster.
Kudumala S.; Freund J.; Hortsch M.; Godenschwege T.A.;
PLoS ONE 8:E76974-E76974(2013)
Cited for: CHARACTERIZATION OF VARIANT VAL-120; CHARACTERIZATION OF VARIANTS MASA GLN-210 AND LYS-309; CHARACTERIZATION OF VARIANTS HYCX GLN-184; TYR-264 AND CYS-1070; MUTAGENESIS OF 1147-LYS--VAL-1153;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.